Market research analysis firm Beauhurst ranks sequencing firm Oxford Nanopore among the highest valued and fastest growing firms in the UK, Forbes's David Prosser reports. This list of five, he adds, includes three biotech firms and two financial technology firms.
Oxford Nanopore was worth some £930 million ($1.29 billion) at its latest fund-raising round, Prosser says. He notes that the company has gone through eight equity fundraisings and has follow-on investment from IP Group, Invesco Perpetual, and Woodford Patient Capital Trust.
The other companies on the Beauhurst list include Stratified Medical, Funding Circle, TransferWise, and Immodulon Therapeutics.
Prosser adds that the ranking also notes that no one company reached 'unicorn' status last year in pounds, but that Oxford Nanopore comes close to that 1-billion mark.